rs77820367
Positions:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000532.5(PCCB):c.872G>A(p.Cys291Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00179 in 1,614,132 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 5 hom. )
Consequence
PCCB
NM_000532.5 missense
NM_000532.5 missense
Scores
4
8
7
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
PCCB (HGNC:8654): (propionyl-CoA carboxylase subunit beta) The protein encoded by this gene is a subunit of the propionyl-CoA carboxylase (PCC) enzyme, which is involved in the catabolism of propionyl-CoA. PCC is a mitochondrial enzyme that probably acts as a dodecamer of six alpha subunits and six beta subunits. This gene encodes the beta subunit of PCC. Defects in this gene are a cause of propionic acidemia type II (PA-2). Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCCB | NM_000532.5 | c.872G>A | p.Cys291Tyr | missense_variant | 8/15 | ENST00000251654.9 | NP_000523.2 | |
PCCB | NM_001178014.2 | c.932G>A | p.Cys311Tyr | missense_variant | 9/16 | NP_001171485.1 | ||
PCCB | XM_011512873.2 | c.872G>A | p.Cys291Tyr | missense_variant | 8/11 | XP_011511175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCCB | ENST00000251654.9 | c.872G>A | p.Cys291Tyr | missense_variant | 8/15 | 1 | NM_000532.5 | ENSP00000251654.4 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 215AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
215
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00133 AC: 335AN: 251462Hom.: 0 AF XY: 0.00136 AC XY: 185AN XY: 135898
GnomAD3 exomes
AF:
AC:
335
AN:
251462
Hom.:
AF XY:
AC XY:
185
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00183 AC: 2679AN: 1461818Hom.: 5 Cov.: 32 AF XY: 0.00174 AC XY: 1265AN XY: 727212
GnomAD4 exome
AF:
AC:
2679
AN:
1461818
Hom.:
Cov.:
32
AF XY:
AC XY:
1265
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00140 AC: 214AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.00130 AC XY: 97AN XY: 74474
GnomAD4 genome
AF:
AC:
214
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
97
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
9
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
25
ExAC
AF:
AC:
143
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Propionic acidemia Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 26, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 24, 2023 | BP5, PS3_supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2024 | Has previously been reported in a patient with propionic acidemia who was heterozygous for C291Y and in whom a second variant in PCCB was not identified; however this patient was also homozygous for a pathogenic variant in the PCCA gene (PMID: 22033733); Expression studies of C291Y in E. coli reported that it is associated with significantly reduced enzyme activity; however, no wild-type controls were used for comparison (PMID: 22033733); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown; This variant is associated with the following publications: (PMID: 25087612, 34426522, 34670123, 22033733, 24448499, 26740555, 27460824, 28050010, 29618726, 28719003, 36099812, 35132093) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 14, 2023 | Variant summary: PCCB c.872G>A (p.Cys291Tyr) results in a non-conservative amino acid change located in the Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (IPR034733) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0018 in 1614132 control chromosomes in the gnomAD database, including 5 homozygotes (gnomAD v4). This frequency is not significantly higher than estimated for a pathogenic variant in PCCB causing Propionic Acidemia (0.0018 vs 0.0025), allowing no conclusion about variant significance. c.872G>A has been reported at a heterozygous state in one individual affected with Propionic Acidemia, whose phenotypes may be fully explained by a co-occurring homozygous pathogenic variant in PCCA (c.1899+4_1899+7del) (Kraus_2012). This variant was also reported in unspecified individuals with idiopathic spontaneous pregnancy losses or individuals undertaking multiple-gene panel testing for CHD, TGA, heterotaxy, without strong evidence for causality (Blue_2022, Buonaiuto_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Propionic Acidemia. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 1.5% of normal activity in E. coli (Kraus_2012). The following publications have been ascertained in the context of this evaluation (PMID: 34670123, 35132093, 22033733). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (Likely pathogenic, n=1, likely benign, n=1, VUS, n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.;D;D;D;.;.;.;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Benign
T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T
Polyphen
P;.;.;.;.;.;.;P;.;.
Vest4
MVP
MPC
0.33
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -7
Find out detailed SpliceAI scores and Pangolin per-transcript scores at